Detailed price information for Rhythm Pharmaceuticals Inc (RYTM-Q) from The Globe and Mail including charting and trades.
Q4 2025 preliminary net product revenues from global sales of IMCIVREE- (setmelanotide) of approximately $57 million for the fourth quarter of 2025, an 11% increase over Q3 2025 -- -- FY 2025 prelimin ...
Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.
Richard Smith's “WhiteGrass” Delivers a Riveting Blend of Cli-Fi, AI Ethics, and Family Drama NY, UNITED STATES, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback